Poster Exhibit 2: Non-prostate Genitourinary Cancers.
出版信息
Can Urol Assoc J. 2021 Jun;15(6 Suppl 2):S84-S98. doi: 10.5489/cuaj.7401.
Abstract
摘要
相似文献
1
Poster Exhibit 2: Non-prostate Genitourinary Cancers.
Can Urol Assoc J. 2021 Jun;15(6 Suppl 2):S84-S98. doi: 10.5489/cuaj.7401.
2
Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer.
Expert Rev Anticancer Ther. 2014 Dec;14(12):1407-9. doi: 10.1586/14737140.2014.953937. Epub 2014 Aug 27.
3
Chronic hepatitis C virus infection and genitourinary cancers: A case-control study.
Semin Oncol. 2020 Apr-Jun;47(2-3):165-167. doi: 10.1053/j.seminoncol.2020.04.005. Epub 2020 May 21.
4
Bisphosphonate anticancer activity in prostate cancer and other genitourinary cancers.
Anticancer Agents Med Chem. 2012 Feb;12(2):129-36. doi: 10.2174/187152012799014995.
5
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
Future Oncol. 2016 Sep;12(17):1971-4. doi: 10.2217/fon-2016-0166. Epub 2016 Jun 17.
6
Physical activity and genitourinary cancer prevention.
Recent Results Cancer Res. 2011;186:43-71. doi: 10.1007/978-3-642-04231-7_3.
7
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Lancet Oncol. 2016 Apr;17(4):464-474. doi: 10.1016/S1470-2045(15)00567-7. Epub 2016 Mar 9.
8
Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis.
JMIR Mhealth Uhealth. 2020 Jul 23;8(7):e17609. doi: 10.2196/17609.
9
Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer.
Pract Radiat Oncol. 2015 Sep-Oct;5(5):e465-e472. doi: 10.1016/j.prro.2015.02.001. Epub 2015 Mar 18.
10
Smoking-related genitourinary cancers: A global call to action in smoking cessation.
Rev Urol. 2016;18(4):194-204. doi: 10.3909/riu0729.
本文引用的文献
1
Kidney Biopsy Adequacy: A Metric-based Study.
Am J Surg Pathol. 2019 Jan;43(1):84-92. doi: 10.1097/PAS.0000000000001102.
2
Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopy.
Nat Biomed Eng. 2017;1. doi: 10.1038/s41551-016-0027. Epub 2017 Feb 6.
3
Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers-a Prospective Double-Blind Clinical Study.
Urology. 2017 Nov;109:134-139. doi: 10.1016/j.urology.2017.08.007. Epub 2017 Aug 14.
4
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.
J Clin Oncol. 2017 Feb 20;35(6):591-597. doi: 10.1200/JCO.2016.70.7398. Epub 2016 Nov 14.
5
Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours.
Ann R Coll Surg Engl. 2016 Nov;98(8):547-551. doi: 10.1308/rcsann.2016.0246. Epub 2016 Aug 9.
6
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.
J Urol. 2016 Oct;196(4):1021-9. doi: 10.1016/j.juro.2016.06.049. Epub 2016 Jun 16.
7
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.
Lancet Oncol. 2016 Jul;17(7):917-927. doi: 10.1016/S1470-2045(16)30107-3. Epub 2016 Jun 5.
8
CUA guidelines on the management of non-muscle invasive bladder cancer.
Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E690-704. doi: 10.5489/cuaj.3320. Epub 2015 Oct 13.
9
Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
Am J Surg Pathol. 2002 May;26(5):551-66. doi: 10.1097/00000478-200205000-00002.
Zotero 插件